Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 16, 2018

View Archived Issues

Vertex announces positive results for VX-150 in relief of acute pain

Novel transgelin-2 agonist reduces asthmatic pulmonary resistance in mice

Overall survival improved with OMS-721 in thrombotic microangiopathy trial

siCAG/CUG shown as promising new gene therapy for cancer

Somatic and neurological effects seen with AGT-181 in patients with MPS type I

First-in-human study of ARO-HBV cleared; ARO-AAT granted U.S. orphan status

FDA grants fast track designation to Allecra's AAI-101 in fixed-dose combination with cefepime

TRDN user survey - We want your opinion

FDA approves Makena subcutaneous atuoinjector

Shire reviews key development highlights of fourth quarter 2017

OR51T1 predicts hormone therapy efficacy in men with mHNPC

Intralytix cleared to begin phase I/IIa trials of bacteriophage preparation

Nodthera patents new NLRP3 inflammasome inhibitors

Agios Pharmaceuticals submits NDA for ivosidenib for acute myeloid leukemia

Results from phase III trial of avelumab in advanced NSCLC

Accro Bioscience divulges necrosis inhibitors

Bristol-Myers Squibb Co. presents new TGFBR inhibitors

CARB-X funds Curza's development of Gram-negative antibiotic program

Pfizer patents novel C5a1 receptor antagonists

Sanofi exercises option to license additional multi-specific Nanobodies from Ablynx

New isochroman derivatives presented by Sunovion Pharmaceuticals

FDA accepts Shire's sBLA for the use of Cinryze in children

Miglustat stabilizes ATB-200 in the circulation of Pompe disease patients

Debiopharm Group acquires minority stake in ABAC Therapeutics

Xeris completes two phase III studies of its ready-to-use glucagon rescue pen

Otsuka Pharmaceutical updates pipeline progress of fourth quarter 2017

Daiichi Sankyo seeks Japanese approval of mirogabalin for peripheral neuropathic pain

Genethon begins trial of gene therapy for Crigler-Najjar Syndrome

Miticure approved in Japan for pediatric patients with house dust mite-induced allergic rhinitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...